2,694
Total Claims
$348K
Drug Cost
419
Beneficiaries
$832
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-29%
Cost per patient vs peers
$832 vs $1,174 avg
+90%
Brand preference vs peers
16.8% vs 8.9% avg
Brand vs Generic
83% generic
Brand: 453 claims · $290K
Generic: 2,241 claims · $58K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 104 | $84K |
| Rivaroxaban | 109 | $82K |
| Sacubitril/Valsartan | 56 | $53K |
| Dapagliflozin Propanediol | 19 | $14K |
| Empagliflozin | 16 | $13K |
| Dabigatran Etexilate Mesylate | 19 | $9,532 |
| Dabigatran Etexilate Mesylate | 24 | $8,886 |
| Evolocumab | 16 | $8,676 |
| Evolocumab | 11 | $6,311 |
| Evolocumab | 11 | $5,980 |
| Ranolazine | 52 | $5,897 |
| Metoprolol Succinate | 320 | $5,013 |
| Potassium Chloride | 82 | $3,388 |
| Isosorbide Mononitrate | 182 | $2,775 |
| Clopidogrel Bisulfate | 201 | $2,590 |
Prescribing Profile
36
Unique Drugs
$246K
Patient Profile
75
Avg Age
46%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About